Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
304901000036113 | Erythromycin (DBL) (erythromycin 250 mg) enteric capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
304911000036110 | Erythromycin (DBL) 250 mg enteric capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Erythromycin (DBL) 250 mg enteric capsule | has intended active ingredient | erythromycin | true | Inferred relationship | Some | 2091436212 | |
Erythromycin (DBL) 250 mg enteric capsule | has manufactured dose form | enteric capsule | true | Inferred relationship | Some | ||
Erythromycin (DBL) 250 mg enteric capsule | has Australian BoSS | erythromycin | true | Inferred relationship | Some | 2091436212 | |
Erythromycin (DBL) 250 mg enteric capsule | has unit of use | capsule | true | Inferred relationship | Some | 2091436213 | |
Erythromycin (DBL) 250 mg enteric capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Erythromycin (DBL) 250 mg enteric capsule | Is a | Erythromycin (DBL) | true | Inferred relationship | Some | ||
Erythromycin (DBL) 250 mg enteric capsule | Is a | erythromycin 250 mg enteric capsule | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Erythromycin (DBL) 250 mg enteric capsule, 25 | has TPUU | True | Erythromycin (DBL) 250 mg enteric capsule | Inferred relationship | Some | 1 |
Erythromycin (DBL) 250 mg enteric capsule, 25, blister pack | has TPUU | True | Erythromycin (DBL) 250 mg enteric capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set